(Q35569078)

8 August 2017

1 reference

title

Drugs for the control of parasitic diseases: current status and development in schistosomiasis (English)

1 reference

8 August 2017

0 references

5

Matthew H Todd

1 reference

8 August 2017

1

Alan Fenwick

1 reference

8 August 2017

3

Dirk Engels

1 reference

8 August 2017

2

Lorenzo Savioli

1 reference

8 August 2017

N. Robert Bergquist

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580962

25 March 2024

language of work or name

1 reference

1 November 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1471492203002460?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

https://api.elsevier.com/content/article/PII:S1471492203002460?httpAccept=text/plain

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

25 March 2024

published in

Trends in Parasitology

1 reference

8 August 2017

volume

19

1 reference

8 August 2017

issue

11

1 reference

8 August 2017

page(s)

509-515

1 reference

The global status of schistosomiasis and its control

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa

25 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Evaluation of efficacy of school-based anthelmintic treatments against anaemia in children in the United Republic of Tanzania

25 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Better health, nutrition and education for the school-aged child. The Partnership for Child Development

25 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

The global epidemiological situation of schistosomiasis and new approaches to control and research

25 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Schistosomiasis control in Brazil

25 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Difficulties and strategies in the control of schistosomiasis in the Philippines.

25 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

The 1992-1999 World Bank Schistosomiasis Research Initiative in China: outcome and perspectives

25 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Evaluation of the 1992-1999 World Bank Schistosomiasis Control Project in China

25 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Schistosomiasis and soil-transmitted helminth infections: forging control efforts

25 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Schistosomiasis control in Ghana: Case management and means for diagnosis and treatment within the health system

25 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Worms: Education and Health Externalities in Kenya

25 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis

25 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa

25 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Field test of the 'dose pole' for praziquantel in Zanzibar

25 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Administration of praziquantel to pregnant and lactating women

25 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Can we deworm this wormy world?

25 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Extending anthelminthic coverage to non-enrolled school-age children using a simple and low-cost method

25 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Praziquantel--its use, cost and possible development of resistance.

25 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Praziquantel and the control of schistosomiasis.

25 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Praziquantel--quality, dosages and markers of resistance

25 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Counterfeit praziquantel.

25 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Resistance of Schistosoma mansoni to praziquantel: is there a problem?

25 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal

25 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Anthelmintic resistance in human helminths: a review

25 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

25 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Synthesis and properties of Praziquantel, a novel broad spectrum anthelmintic with excellent activity against Schistosomes and Cestodes

25 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Amino acid derived heterocycles: lewis acid catalyzed and radical cyclizations from peptide acetals

25 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

25 March 2024

Praziquantel

37

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel

25 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Synthesis of praziquantel derivatives and their in vitro activity against adult Clonorchis sinensis

25 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

The potential of artemether for the control of schistosomiasis

25 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni

25 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial

25 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials

25 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

A safe, effective, herbal antischistosomal therapy derived from myrrh.

25 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa

25 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

Mortality due to schistosomiasis mansoni: a field study in Sudan

25 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

An attempt to study the case fatality rate in Schistosoma japonicum infection in the Philippines

25 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.PT.2003.09.005

25 March 2024

Identifiers

1 reference

8 August 2017

1 reference